Supervisory Board

Kiadis Pharma’s Supervisory Board supervises and advises Management on the general course of affairs of the Company and its affiliated enterprises.

Mark Wegter

Supervisory Board Member

Mark Wegter joined our Board in 2001 as a representative of LSP, where he is a Managing Partner. He has been the company’s Chairman since. Prior to joining LSP, Mark worked as a Senior Analyst at ING Corporate and Investment Banking. Mark brings 20 years of hands-on finance, investment and board experience in the biotechnology sector to the Kiadis team, playing an active role in its growth and strategic direction. For the past 10 years, he has focused his professional attention to investing in publicly listed biotech companies that fall within the small- and mid-cap segment, building a track record of taking  positions in undervalued companies and holding on to them long term. Mark holds a Master’s degree in Business Economics from the Erasmus University of Rotterdam.

Jérémie Girard

Supervisory Board Member

Mr. Jérémie Girard was born in 1983 and is a French national. He graduated from the “Ecole Polytechnique” and the “Ecole des Mines de Paris”, France, with engineer degrees, specializing in cellular biology and biotechnology. Mr. Girard started his career in Healthcare Venture Capital then joined Sanofi where he held various roles of increasing responsibilities. He is currently the Head of Finance Global R&D at Sanofi.

Kripa Ram

Supervisory Board Member

Dr. Kripa Ram was born in India in 1963 and is an American national. He graduated from Rutgers University, NJ, USA with a Ph.D. in Biochemical Engineering. During his 30-year professional career, he has worked at Merck & Co, GlaxoSmithKline, Biogen, AstraZeneca, and Sanofi in positions of increasing responsibilities in various aspects of CMC development, scale-up and manufacturing. He has played a key role in bringing several biopharmaceutical products to market. Dr. Ram is currently the Head of Global CMC Development at Sanofi with responsibilities for process, analytics, formulation and clinical manufacture for Sanofi Pharma R&D pipeline.

Frank Nestle

Supervisory Board Member

Dr. Frank Nestle is currently Head of Research and Chief Scientific Officer at Sanofi with responsibility for Sanofi’s main therapeutic areas of Immunology & Inflammation, Oncology including Immuno-Oncology, Neuroscience, Rare Diseases including Rare Blood Disorders and Genomic Medicine with a mandate to innovate and accelerate first and best in class medicines from discovery to clinical proof-of-concept. Dr. Nestle is a Fellow of the National Academy of Medical Sciences, National Institute for Health Research (NIHR) Senior Investigator Emeritus, Professor Emeritus King’s College London and past President of the Federation of Clinical Immunology Societies. Dr. Nestle has published over 220 scientific articles (H index 82; > 32000 citations) in publications such as Nature, Nature Medicine, Cell and New England Journal of Medicine. He has received multiple prizes including the Alfred Marchionini Research Award (20th World Congress of Dermatology) and the American Skin Association Achievement Award (Tricontinental Meeting of the Societies of Investigative Dermatology).

Dr. Robert Soiffer

Supervisory Board Member

Dr. Soiffer became a member of the Supervisory Board on June 28, 2016. Dr. Soiffer is currently a Professor at Harvard University Medical School, Chief of the Division of Hematologic Malignancies at the Dana-Farber Cancer Institute, or DFCI and Codirector of the Adult Stem Cell Transplantation Program at the DFCI. Dr. Soiffer joined the DFCI in 1988, after completing a medical oncology fellowship. Dr. Soiffer sits on the board of the U.S. National Marrow Donor Program’s Be the Match Registry, or NMDP and on the Massachusetts Board of the Leukemia and Lymphoma Society. Dr. Soiffer is also Chairman of the Advisory Committee for International Blood and Marrow Research. From May 7, 2014 through May 7, 2015, Dr. Soiffer served as a member of Kiadis Pharma Netherlands B.V.’s Scientific Advisory Board while it was conducting clinical trials in Canada and Europe.

Mark Wegter

Supervisory Board Member

Jérémie Girard

Supervisory Board Member

Kripa Ram

Supervisory Board Member

Frank Nestle

Supervisory Board Member

Dr. Robert Soiffer

Supervisory Board Member